Maria João Valente

Dr. Maria João Valente

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2013 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
MVMaria João Valente
Maria João Valente
Paula Guedes de PinhoPaula Guedes de Pinho
Paula Guedes de Pinho
MBMaria de Lourdes Bastos
Maria de Lourdes Bastos
Félix CarvalhoFélix Carvalho
Félix Carvalho
Márcia CarvalhoMárcia Carvalho
Márcia Carvalho

1 January 2011 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
MVMaria João Valente
Maria João Valente
ABAna F. Baltazar
Ana F. Baltazar
Rui HenriqueRui Henrique
Rui Henrique
Leticia M. EstevinhoLeticia M. Estevinho
Leticia M. Estevinho
Márcia CarvalhoMárcia Carvalho
Márcia Carvalho


Verified
Journal Article
Open access
PDF file
Susana CoimbraSusana Coimbra
Susana Coimbra
Susana RochaSusana Rocha
Susana Rocha
NSNícia Reis Sousa
Nícia Reis Sousa
CCCristina Catarino
Cristina Catarino
Luís BeloLuís Belo
Luís Belo
Alice Santos-SilvaAlice Santos-Silva
Alice Santos-Silva
Gadolinium-based contrast agents (GBCAs) have been used for more than 30 years to improve magnetic resonance imaging, a crucial tool for medical diagnosis and treatment monitoring across multiple clinical settings. Studies have shown that exposure to GBCAs is associated with gadolinium release and tissue deposition that may cause short- and long-term toxicity in several organs, including the kidney, the main excretion organ of most GBCAs. Considering the increasing prevalence of chronic kidney disease worldwide and that most of the complications following GBCA exposure are associated with renal dysfunction, the mechanisms underlying GBCA toxicity, especially renal toxicity, are particularly important. A better understanding of the gadolinium mechanisms of toxicity may contribute to clarify the safety and/or potential risks associated with the use of GBCAs. In this work, a review of the recent literature concerning gadolinium and GBCA mechanisms of toxicity was performed.

14 November 2012 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MVMaria João Valente
Maria João Valente
Félix CarvalhoFélix Carvalho
Félix Carvalho
MBM.D.L. Bastos
M.D.L. Bastos
Paula Guedes de PinhoPaula Guedes de Pinho
Paula Guedes de Pinho
Márcia CarvalhoMárcia Carvalho
Márcia Carvalho
Cocaine is a potent psychoactive illicit substance and its abuse represents a major health burden worldwide. The pharmacodynamics and toxicity of cocaine have been extensively documented, and are generally associated to its affinity towards neurotransmitters transporters and several receptors. However, drug-related formation of reactive compounds, as is the case of pro-oxidant reactive species, and interaction at molecular level is still an understudied matter. The involvement of oxidative stress (OS) in cocaine-induced toxicity has been reported in both human and animal models, in several organs and systems, including heart, liver, kidney, and central nervous system (CNS). Cytochrome P450 (CYP450)-mediated cocaine metabolism yields the reactive pro-oxidant compound norcocaine (NCOC) and further oxidative metabolites. Special emphasis should be given to the stable radical norcocaine nitroxide (NCOC-NO·), which plays a key role in cocaine-induced hepatotoxicity, either by entering a futile redox cycle with an N-oxidative metabolite, or by being further oxidized to a highly reactive ion. In fact, cocaine-induced generation of reactive oxygen species (ROS) and consequent OS has been postulated based on the reactivity of cocaine N-oxidative metabolites. Depletion of cellular antioxidant defenses and impairment of mitochondrial respiration have also been considered important causes of ROS production, and subsequent cell death mediated by cocaine. The present review provides a thorough description of the current knowledge on cocaine oxidative metabolism and its role on drug-induced liver and kidney damage.

9 January 2017 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
MVMaria João Valente
Maria João Valente
MBMaria de Lourdes Bastos
Maria de Lourdes Bastos
Eduarda FernandesEduarda Fernandes
Eduarda Fernandes
Félix CarvalhoFélix Carvalho
Félix Carvalho
Paula Guedes de PinhoPaula Guedes de Pinho
Paula Guedes de Pinho
Márcia CarvalhoMárcia Carvalho
Márcia Carvalho